U.S. markets close in 5 hours 54 minutes

Femasys Inc. (FEMY)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
7.00-0.01 (-0.14%)
As of 10:01AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close7.01
Bid6.93 x 2200
Ask7.17 x 1000
Day's Range7.00 - 7.11
52 Week Range6.50 - 13.75
Avg. Volume32,620
Market Cap82.598M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-4.91
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est21.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for FEMY

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Femasys Inc.
    Daily – Vickers Top Buyers & Sellers for 06/28/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    4 months agoArgus Research
View more
  • GlobeNewswire

    Femasys Inc. to Present at The MedTech Conference

    ATLANTA, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health, today announced that Kathy Lee-Sepsick, chairman, president and chief executive officer, will participate in a presentation at The MedTech Conference. Ms. Lee-Sepsick will speak on a panel in a session, entitled, “Early-Stage Medtech and Goin

  • GlobeNewswire

    Femasys Inc. To Join the Russell Microcap® Index

    ATLANTA, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY) (“Femasys” or the “Company”), a biomedical company developing a suite of product candidates to transform women’s healthcare with minimally invasive, non-surgical, in-office technologies, announced that the Company has been added to the Russell Microcap® Index today when the U.S. market opened. The Russell Microcap Index is widely used by investment managers and institutional investors for index funds and as benchmarks for ac

  • Simply Wall St.

    Bullish insiders bet US$2.6m on Femasys Inc. (NASDAQ:FEMY)

    In the last year, multiple insiders have substantially increased their holdings of Femasys Inc. ( NASDAQ:FEMY ) stock...